Shares of Unilife spiked this week after it revealed a $60 million debt financing agreement with healthcare investment firm OrbiMed. Unilife CEO Alan Shortall expects to build on those gains as additional deals and customer wins are announced. $40 million was funded to Unilife at the closing of the deal, which it will use to run the business as it moves toward its commercial rollout, while two additional tranches of $10 million each will be provided to Unilife in December 2014 and June 2015.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

If you liked this article you might like

Stocks Under $10 Portfolio: ON Semi and McDermott Make Bold Moves

Stocks Under $10 Portfolio: Tax-Loss Selling Weighs on Indices

Stocks Under $10 Portfolio: Bulls Catch Another Wave in an Endless Summer

Stocks Under $10: Friday 13 Turns Good Luck to Bad

Stocks Under $10: Friday 13 Turns Good Luck to Bad

Unilife (UNIS) Stock Soars on Amgen Partnership